<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1270" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1270/" /><meta name="ncbi_pagename" content="Rhizomelic Chondrodysplasia Punctata Type 1 - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Rhizomelic Chondrodysplasia Punctata Type 1 - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Rhizomelic Chondrodysplasia Punctata Type 1" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2012/09/13" /><meta name="citation_author" content="Nancy E Braverman" /><meta name="citation_author" content="Ann B Moser" /><meta name="citation_author" content="Steven J Steinberg" /><meta name="citation_pmid" content="20301447" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1270/" /><meta name="citation_keywords" content="RCDP1" /><meta name="citation_keywords" content="RCDP1" /><meta name="citation_keywords" content="Peroxisomal targeting signal 2 receptor" /><meta name="citation_keywords" content="PEX7" /><meta name="citation_keywords" content="Rhizomelic Chondrodysplasia Punctata Type 1" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Rhizomelic Chondrodysplasia Punctata Type 1" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Nancy E Braverman" /><meta name="DC.Contributor" content="Ann B Moser" /><meta name="DC.Contributor" content="Steven J Steinberg" /><meta name="DC.Date" content="2012/09/13" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1270/" /><meta name="description" content="Rhizomelic chondrodysplasia punctata type 1 (RCDP1) classic type, a peroxisome biogenesis disorder (PBD), is characterized by proximal shortening of the humerus and to a lesser degree the femur (rhizomelia), punctate calcifications in cartilage with epiphyseal and metaphyseal abnormalities (chondrodysplasia punctata, or CDP), coronal clefts of the vertebral bodies, and cataracts that are usually present at birth or appear in the first few months of life. Birth weight, length, and head circumference are often at the lower range of normal; postnatal growth deficiency is profound. Intellectual disability is severe, and the majority of children develop seizures. Most affected children do not survive the first decade of life; a proportion die in the neonatal period. A milder phenotype in which all affected individuals have congenital cataracts and chondrodysplasia is now recognized; some do not have rhizomelia, and some have less severe intellectual disability and growth deficiency." /><meta name="og:title" content="Rhizomelic Chondrodysplasia Punctata Type 1" /><meta name="og:type" content="book" /><meta name="og:description" content="Rhizomelic chondrodysplasia punctata type 1 (RCDP1) classic type, a peroxisome biogenesis disorder (PBD), is characterized by proximal shortening of the humerus and to a lesser degree the femur (rhizomelia), punctate calcifications in cartilage with epiphyseal and metaphyseal abnormalities (chondrodysplasia punctata, or CDP), coronal clefts of the vertebral bodies, and cataracts that are usually present at birth or appear in the first few months of life. Birth weight, length, and head circumference are often at the lower range of normal; postnatal growth deficiency is profound. Intellectual disability is severe, and the majority of children develop seizures. Most affected children do not survive the first decade of life; a proportion die in the neonatal period. A milder phenotype in which all affected individuals have congenital cataracts and chondrodysplasia is now recognized; some do not have rhizomelia, and some have less severe intellectual disability and growth deficiency." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1270/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/rcdp/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1270/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D5E73E04137810000000000E90056.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1270_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1270_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/rtps/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/riboflavin-tn/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1270_"><span class="title" itemprop="name">Rhizomelic Chondrodysplasia Punctata Type 1</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: RCDP1</div><p class="contrib-group"><span itemprop="author">Nancy E Braverman</span>, MS, MD, <span itemprop="author">Ann B Moser</span>, BA, and <span itemprop="author">Steven J Steinberg</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1270_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1270_ai__"><div class="contrib half_rhythm"><span itemprop="author">Nancy E Braverman</span>, MS, MD<div class="affiliation small">Departments of Human Genetics and Pediatrics<br />McGill University - Montreal Children's Hospital Research Institute<br />Montreal, Quebec, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.lligcm@namrevarb.ycnan" class="oemail">ac.lligcm@namrevarb.ycnan</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ann B Moser</span>, BA<div class="affiliation small">Department of Neurogenetics<br />Kennedy Krieger Institute<br />Baltimore, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.regeirkydennek@aresom" class="oemail">gro.regeirkydennek@aresom</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Steven J Steinberg</span>, PhD<div class="affiliation small">Department of Neurogenetics<br />Kennedy Krieger Institute<br />Baltimore, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.regeirkydennek@sgrebniets" class="oemail">gro.regeirkydennek@sgrebniets</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">November 16, 2001</span>; Last Update: <span itemprop="dateModified">September 13, 2012</span>.</p><p><em>Estimated reading time: 18 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="rcdp.Summary" itemprop="description"><h2 id="_rcdp_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Rhizomelic chondrodysplasia punctata type 1 (RCDP1) classic type, a peroxisome biogenesis disorder (PBD), is characterized by proximal shortening of the humerus and to a lesser degree the femur (rhizomelia), punctate calcifications in cartilage with epiphyseal and metaphyseal abnormalities (chondrodysplasia punctata, or CDP), coronal clefts of the vertebral bodies, and cataracts that are usually present at birth or appear in the first few months of life. Birth weight, length, and head circumference are often at the lower range of normal; postnatal growth deficiency is profound. Intellectual disability is severe, and the majority of children develop seizures. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children do not survive the first decade of life; a proportion die in the neonatal period. A milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in which all affected individuals have <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts and chondrodysplasia is now recognized; some do not have rhizomelia, and some have less severe intellectual disability and growth deficiency.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of RCDP1 is based on clinical findings and confirmed by biochemical or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Biochemical tests of peroxisome function include: red blood cell concentration of plasmalogens (deficient), plasma concentration of phytanic acid (elevated), and plasma concentration of very long chain fatty acids (VLCFA) (normal), which has consistently predicted the PEX7 receptor defect in RCDP1. <i>PEX7</i>, which encodes the receptor for a subset of peroxisomal matrix enzymes, is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause RCDP1.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management is supportive and limited by the multiple handicaps present at birth and poor outcome. Cataract extraction may restore some vision. Physical therapy is recommended to improve contractures; orthopedic procedures may improve function in some individuals.</p><p><i>Prevention of primary manifestations</i>: Dietary restriction of phytanic acid to avoid the consequences of phytanic acid accumulation over time may benefit individuals with milder forms of RCDP.</p><p><i>Prevention of secondary manifestations</i>: Poor feeding and recurrent aspiration may necessitate placement of a gastrostomy tube; attention to respiratory function with administration of influenza vaccine and RSV monoclonal antibody; docosohexanoic acid (DHA) supplementation in those who are deficient.</p><p><i>Surveillance</i>: Monitoring of growth and development and regular assessments for seizure control, vision, hearing, contractures, and orthopedic complications.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>RCDP1 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a 25% chance of inheriting both pathogenic alleles and being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of inheriting one pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> and being an unaffected <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of inheriting both normal alleles. Once the pathogenic variants have been identified in an affected family member, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> of at-risk relatives and prenatal testing for pregnancies at increased risk are possible. Prenatal diagnosis by assay of plasmalogen biosynthesis is possible for pregnancies at 25% risk for RCDP1.</p></div></div><div id="rcdp.Diagnosis"><h2 id="_rcdp_Diagnosis_">Diagnosis</h2><div id="rcdp.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p><b>Classic rhizomelic chondrodysplasia punctata type 1 (RCDP1)</b> is recognized <b>in the neonatal period</b> by the presence of:</p><ul><li class="half_rhythm"><div><b>Cataracts</b></div></li><li class="half_rhythm"><div><b>Skeletal features.</b> Classic findings include the following:</div><ul><li class="half_rhythm"><div>Rhizomelia (proximal shortening of the long bones)</div></li><li class="half_rhythm"><div>Chondrodysplasia punctata (CDP): punctate calcifications observed in radiographs in the epiphyseal cartilage at the knee, hip, elbow, and shoulder that can be more extensive, involving the hyoid bone, larynx, costochondral junctions, and vertebrae. Metaphyseal abnormalities may be present.</div></li><li class="half_rhythm"><div>Radiolucent coronal clefts of the vertebral bodies on lateral spine radiographs that represent unossified cartilage</div></li></ul></li></ul><p><b>Classic RCDP1</b> is recognized <b>in childhood</b> by the presence of:</p><ul><li class="half_rhythm"><div>Congenital cataracts</div></li><li class="half_rhythm"><div>Severe intellectual disability</div></li><li class="half_rhythm"><div>Profound growth retardation</div></li><li class="half_rhythm"><div>Resolution of the punctate calcifications leaving abnormal epiphyses and flared and irregular metaphyses after age one to three years</div></li><li class="half_rhythm"><div>Possible calcification of the intervertebral discs</div></li></ul><p><b>Milder RCDP1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></b> is recognized by:</p><ul><li class="half_rhythm"><div>Congenital cataracts</div></li><li class="half_rhythm"><div>Chondrodysplasia (manifesting as mild epiphyseal changes)</div></li><li class="half_rhythm"><div>Variable rhizomelia</div></li><li class="half_rhythm"><div>Milder intellectual disability and growth deficiency</div></li></ul></div><div id="rcdp.Testing"><h3>Testing</h3><p><b>Biochemical tests.</b> Three biochemical tests of peroxisome function are routinely used to confirm the diagnosis of RCDP1:</p><ul><li class="half_rhythm"><div>Red blood cell concentration of plasmalogens (<a class="figpopup" href="/books/NBK1270/table/rcdp.T.values_for_red_blood_cell_plasmal/?report=objectonly" target="object" rid-figpopup="figrcdpTvaluesforredbloodcellplasmal" rid-ob="figobrcdpTvaluesforredbloodcellplasmal">Table 1</a>)</div></li><li class="half_rhythm"><div>Plasma concentration of phytanic acid (<a class="figpopup" href="/books/NBK1270/table/rcdp.T.plasma_concentration_of_phytanic/?report=objectonly" target="object" rid-figpopup="figrcdpTplasmaconcentrationofphytanic" rid-ob="figobrcdpTplasmaconcentrationofphytanic">Table 2</a>)</div></li><li class="half_rhythm"><div>Plasma concentration of very long chain fatty acids (VLCFA)</div></li></ul><p>The finding of a deficiency of plasmalogens in red blood cells, increased plasma concentration of phytanic acid, and normal plasma concentration of very long chain fatty acids has consistently predicted the <i>PEX7</i> receptor defect in RCDP1.</p><p>These assays are extremely specialized and are reliably performed in a limited number of laboratories worldwide.</p><div id="rcdp.T.values_for_red_blood_cell_plasmal" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Values for Red Blood Cell Plasmalogens (Dimethylacetals) in RCDP1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1270/table/rcdp.T.values_for_red_blood_cell_plasmal/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rcdp.T.values_for_red_blood_cell_plasmal_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_1_1" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">C16 Saturated Dimethylacetals (DMA) to C16 Saturated Fatty Acid</th></tr><tr><th headers="hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_1_1" id="hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_2_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></th><th headers="hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_1_1" id="hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mean</th><th headers="hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_1_1" id="hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Range</th></tr></thead><tbody><tr><td headers="hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_1_1 hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Normal</b></td><td headers="hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_1_1 hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.077&#x000b1;0.009</td><td headers="hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_1_1 hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.051-0.090</td></tr><tr><td headers="hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_1_1 hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Abnormal (RCDP1)</b></td><td headers="hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_1_1 hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_1_1 hd_h_rcdp.T.values_for_red_blood_cell_plasmal_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.001-0.025&#x000a0;<sup>1</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Values are expressed as a ratio of C16 or C18 dimethylacetyls to fatty acid molecules.</p></div></dd><dt>1. </dt><dd><div id="rcdp.TF.1.1"><p class="no_margin">Values are for the classic RCDP1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>; individuals with a mild RCDP1 phenotype may fall outside this range.</p></div></dd></dl></div></div></div><div id="rcdp.T.plasma_concentration_of_phytanic" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Plasma Concentration of Phytanic Acid in RCDP1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1270/table/rcdp.T.plasma_concentration_of_phytanic/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rcdp.T.plasma_concentration_of_phytanic_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rcdp.T.plasma_concentration_of_phytanic_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></th><th id="hd_h_rcdp.T.plasma_concentration_of_phytanic_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mean</th><th id="hd_h_rcdp.T.plasma_concentration_of_phytanic_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Range</th></tr></thead><tbody><tr><td headers="hd_h_rcdp.T.plasma_concentration_of_phytanic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Normal</b></td><td headers="hd_h_rcdp.T.plasma_concentration_of_phytanic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.80 &#x000b5;g/mL &#x000b1; 0.40</td><td headers="hd_h_rcdp.T.plasma_concentration_of_phytanic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0-2.5 &#x000b5;g/mL&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_rcdp.T.plasma_concentration_of_phytanic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Abnormal (RCDP1)</b></td><td headers="hd_h_rcdp.T.plasma_concentration_of_phytanic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_rcdp.T.plasma_concentration_of_phytanic_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;300 &#x000b5;g/mL</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="rcdp.TF.2.1"><p class="no_margin">Plasma concentration of phytanic acid varies with dietary intake of animal fat. It can be normal in infants with RCDP1 because breast milk is low in phytanic acid and most formulas use vegetable fat.</p></div></dd></dl></div></div></div><p><b>Assays in cultured skin fibroblasts</b></p><ul><li class="half_rhythm"><div>Defective plasmalogen biosynthesis, defective phytanic acid (PA) oxidation, and normal VLCFA oxidation are confirmed in cultured fibroblasts.</div></li><li class="half_rhythm"><div>The absence of processed thiolase is determined in some laboratories.</div></li><li class="half_rhythm"><div>The fibroblast assays allow more complete characterization of peroxisomal functions and are critical in establishing the diagnosis in individuals with milder forms of RCDP1, whose plasmalogen levels may not be markedly abnormal.</div></li></ul><div id="rcdp.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p><b>Gene.</b>
<i>PEX7</i>, which encodes the receptor for a subset of peroxisomal matrix enzymes, is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause RCDP1.</p><div id="rcdp.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Rhizomelic Chondrodysplasia Punctata Type 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1270/table/rcdp.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rcdp.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_3" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency&#x000a0;<sup>3</sup></th></tr><tr><th headers="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_4" id="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">2 variants</th><th headers="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_4" id="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 variant</th></tr></thead><tbody><tr><td headers="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX7</i></td><td headers="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants&#x000a0;<sup>3</sup></td><td headers="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">94%&#x000a0;<sup>4</sup></td><td headers="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants&#x000a0;<sup>5</sup></td><td headers="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1270/table/rcdp.T.selected_pex7_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figrcdpTselectedpex7pathogenicvariants" rid-ob="figobrcdpTselectedpex7pathogenicvariants">p.Leu292Ter</a>, <a class="figpopup" href="/books/NBK1270/table/rcdp.T.selected_pex7_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figrcdpTselectedpex7pathogenicvariants" rid-ob="figobrcdpTselectedpex7pathogenicvariants">p.Gly217Arg</a>, <a class="figpopup" href="/books/NBK1270/table/rcdp.T.selected_pex7_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figrcdpTselectedpex7pathogenicvariants" rid-ob="figobrcdpTselectedpex7pathogenicvariants">p.Ala218Val</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_rcdp.T.molecular_genetic_testing_used_in_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">51%-68% of pathogenic alleles</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="rcdp.TF.3.1"><p class="no_margin">See <a href="/books/NBK1270/#rcdp.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="rcdp.TF.3.2"><p class="no_margin">See <a href="#rcdp.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="rcdp.TF.3.3"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>4. </dt><dd><div id="rcdp.TF.3.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, partial-, whole-, or multigene deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="rcdp.TF.3.5"><p class="no_margin">Some laboratories may offer <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of select exons; exons tested may vary by laboratory.</p></div></dd><dt>4. </dt><dd><div id="rcdp.TF.3.4_1"><p class="no_margin">Sequence analysis of <i>PEX7</i> coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions in 133 individuals with RCDP1 from the United States and the Netherlands identified 97% of pathogenic alleles [<a class="bk_pop" href="#rcdp.REF.braverman.2002.284">Braverman et al 2002</a>, <a class="bk_pop" href="#rcdp.REF.motley.2002.612">Motley et al 2002</a>]. Note: In all individuals with biochemically confirmed RCDP1, at least one pathogenic <i>PEX7</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> was identified.</p></div></dd><dt>5. </dt><dd><div id="rcdp.TF.3.5_1"><p class="no_margin">Targeted analysis for pathogenic variants refers to testing for specific common variant(s). Variants detected may differ among laboratories.</p></div></dd><dt>6. </dt><dd><div id="rcdp.TF.3.6"><p class="no_margin"><a class="figpopup" href="/books/NBK1270/table/rcdp.T.selected_pex7_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figrcdpTselectedpex7pathogenicvariants" rid-ob="figobrcdpTselectedpex7pathogenicvariants">p.Leu292Ter</a> was the most common, accounting for 51% of alleles; <a class="figpopup" href="/books/NBK1270/table/rcdp.T.selected_pex7_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figrcdpTselectedpex7pathogenicvariants" rid-ob="figobrcdpTselectedpex7pathogenicvariants">c.903+1G&#x0003e;C</a>, <a class="figpopup" href="/books/NBK1270/table/rcdp.T.selected_pex7_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figrcdpTselectedpex7pathogenicvariants" rid-ob="figobrcdpTselectedpex7pathogenicvariants">p.Gly217Arg</a>, and <a class="figpopup" href="/books/NBK1270/table/rcdp.T.selected_pex7_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figrcdpTselectedpex7pathogenicvariants" rid-ob="figobrcdpTselectedpex7pathogenicvariants">p.Ala218Val</a> together account for 17% of alleles.</p></div></dd></dl></div></div></div></div></div><div id="rcdp.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">When the diagnosis of RCDP is considered, blood should be sent first for measurement of red blood cell plasmalogen, plasma phytanic acid, and plasma very long chain fatty acid concentrations.</p></dd><dt>2.</dt><dd><p class="no_top_margin">When abnormalities are identified (see 1), the diagnosis is confirmed by enzymatic assays in cultured fibroblasts.</p></dd><dt>3.</dt><dd><p class="no_top_margin">Molecular genetic testing is used to identify the two pathogenic variants in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, establish <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>, and enable <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> and <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> of at-risk relatives.</p></dd></dl></div></div><div id="rcdp.Clinical_Characteristics"><h2 id="_rcdp_Clinical_Characteristics_">Clinical Characteristics</h2><div id="rcdp.Clinical_Description"><h3>Clinical Description</h3><div id="rcdp.Classic_RCDP1"><h4>Classic RCDP1</h4><p>The characteristic clinical features observed in RCDP1 are skeletal abnormalities, cataracts, growth retardation, and intellectual disability. The majority of children do not survive beyond the first decade of life and a proportion die in the neonatal period. In a review of 69 children with RCDP diagnosed by the Peroxisomal Diseases Laboratory at the Kennedy Krieger Institute, 60% of children survived the first year and 39% the second; a few survived beyond age ten years. In a review of 35 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children older than age one month, <a class="bk_pop" href="#rcdp.REF.white.2003.332">White et al [2003]</a> reported 90% survival at age one year, 50% survival to age six years, and approximately 20% survival at age 12 years. Most deaths were secondary to respiratory complications. Clinical experience suggests that neonatal deaths have been associated with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease or pulmonary hypoplasia [<a class="bk_pop" href="#rcdp.REF.oswald.2011.3160">Oswald et al 2011</a>].</p><p><b>Skeletal findings.</b> Infants with RCDP1 have bilateral shortening of the humerus and to a lesser degree the femur. They typically have contractures and stiff, painful joints, causing irritability in infancy. Cartilaginous structures of the face are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, resulting in frontal bossing and a short, concave nasal ridge.</p><p><b>Cataracts.</b> Bilateral cortical cataracts develop in virtually all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. They are usually present at birth or appear in the first few months of life and are progressive.</p><p><b>Growth retardation.</b> Whereas birth weight, length, and head circumference are often at the lower range of normal, postnatal growth deficiency is profound.</p><p><b>Intellectual disability.</b> Developmental quotients are below 30. Early developmental skills such as smiling and recognizing voices are achieved by most children with RCDP, but at delayed ages. Skills usually achieved in normal children beyond age six months are never seen [<a class="bk_pop" href="#rcdp.REF.white.2003.332">White et al 2003</a>].</p><p>The majority of children develop seizures.</p><p>Routine brain imaging is normal or has shown cerebral and cerebellar atrophy with enlargement of the ventricles and CSF spaces [<a class="bk_pop" href="#rcdp.REF.powers.1999.129">Powers et al 1999</a>]. MR imaging and MR spectroscopy have shown delayed myelinization, signal abnormalities in supratentorial white matter, decreased choline-to-creatine ratios, and increased levels of mobile lipids, thought to reflect the deficiency of plasmalogens, which are substantial components of myelin [<a class="bk_pop" href="#rcdp.REF.alkan.2003.77">Alkan et al 2003</a>, <a class="bk_pop" href="#rcdp.REF.bamsmengerink.2006.798">Bams-Mengerink et al 2006</a>].</p><p><b>Other.</b> Most children with RCDP1 have recurrent respiratory tract infections caused by neurologic compromise, aspiration, immobility, and a small chest with restricted expansion.</p><p>Radiologic and MRI evidence of multilevel cervical stenosis with or without compression of the spinal cord has been observed. Spinal cord compression may complicate the neurologic picture, which often includes spastic quadriplegia [<a class="bk_pop" href="#rcdp.REF.khanna.2001.63">Khanna et al 2001</a>].</p><p>Ichthyotic skin changes are noted in fewer than one third of individuals.</p><p>Approximately 5%-10% of individuals have a cleft of the soft palate.</p><p>Other malformations observed in individuals with RCDP1 include <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease and ureteropelvic junction (UPJ) obstruction.</p></div><div id="rcdp.Mild_RCDP1"><h4>Mild RCDP1</h4><p>Only a few individuals with milder forms of RCDP1 have been described. All have had chondrodysplasia and cataracts but variable expression of punctate calcifications, rhizomelia, growth retardation, and intellectual disability [<a class="bk_pop" href="#rcdp.REF.braverman.2002.284">Braverman et al 2002</a>, <a class="bk_pop" href="#rcdp.REF.bamsmengerink.2006.798">Bams-Mengerink et al 2006</a>]. One child, presenting with developmental delay and poor growth, subsequently developed <a href="/books/n/gene/rp-overview/">retinitis pigmentosa</a> and peripheral neuropathy, features overlapping those of adult <a href="/books/n/gene/refsum/">Refsum disease</a> [<a class="bk_pop" href="#rcdp.REF.braverman.2002.284">Braverman et al 2002</a>]. Thus, it is likely that a continuum of phenotypes will emerge within the RCDP group. Molecular analysis of <i>PEX7</i> may identify individuals with unusual phenotypes.</p></div></div><div id="rcdp.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>The degree of plasmalogen deficiency correlates directly with phenotypic severity:</p><ul><li class="half_rhythm"><div>Individuals in the milder RCDP group exhibit intermediate defects in fibroblast plasmalogen synthesis and RBC plasmalogen concentrations that are approximately 30% of the mean in controls and more than two standard deviations above the mean in children with classic RCDP.</div></li><li class="half_rhythm"><div>Individuals with more variant phenotypes have near-normal plasmalogen biochemistry.</div></li><li class="half_rhythm"><div>Defects in phytanic acid oxidation in fibroblast assays are severe in all <i>PEX7</i> defects.</div></li></ul><p>Some correlations between the predicted severity of <i>PEX7</i> pathogenic variants and <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> have emerged:</p><ul><li class="half_rhythm"><div>All individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <a class="figpopup" href="/books/NBK1270/table/rcdp.T.selected_pex7_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figrcdpTselectedpex7pathogenicvariants" rid-ob="figobrcdpTselectedpex7pathogenicvariants">p.Leu292Ter</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> studied thus far have had classic RCDP1.</div></li><li class="half_rhythm"><div>In individuals who are compound heterozygotes for <a class="figpopup" href="/books/NBK1270/table/rcdp.T.selected_pex7_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figrcdpTselectedpex7pathogenicvariants" rid-ob="figobrcdpTselectedpex7pathogenicvariants">p.Leu292Ter</a> and another <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the effect of the other <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> is important in determining the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Several <i>PEX7</i> alleles that are associated with a milder RCDP phenotype, adult Refsum disease, or <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts have been identified. It is predicted that these encode either residual amounts of a normal Pex7 protein or a defective protein with residual function [<a class="bk_pop" href="#rcdp.REF.braverman.2002.284">Braverman et al 2002</a>, <a class="bk_pop" href="#rcdp.REF.motley.2002.612">Motley et al 2002</a>, <a class="bk_pop" href="#rcdp.REF.van_den_brink.2003.471">van den Brink et al 2003</a>].</div></li></ul></div><div id="rcdp.Penetrance"><h3>Penetrance</h3><p>Penetrance is complete and the same for either sex.</p></div><div id="rcdp.Nomenclature"><h3>Nomenclature</h3><p>RCDP1 is one of two groups of peroxisome biogenesis disorders (PBD). The other PBD group is the <a href="/books/n/gene/pbd/">Zellweger syndrome spectrum</a>.</p><p>Although individuals with RCDP1 have a perturbation in matrix protein import consistent with a peroxisomal assembly defect, they have a biochemical, cellular, and clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> distinct from PBD of the Zellweger syndrome spectrum.</p></div><div id="rcdp.Prevalence"><h3>Prevalence</h3><p>The prevalence of RCDP1 is estimated to be lower than 1:100,000. The disorder is pan ethnic. The high frequency of the <a class="figpopup" href="/books/NBK1270/table/rcdp.T.selected_pex7_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figrcdpTselectedpex7pathogenicvariants" rid-ob="figobrcdpTselectedpex7pathogenicvariants">p.Leu292Ter</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> is secondary to a <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> in individuals of Northern European descent [<a class="bk_pop" href="#rcdp.REF.braverman.2000.181">Braverman et al 2000</a>].</p></div></div><div id="rcdp.Genetically_Related_Allelic_Disorde"><h2 id="_rcdp_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>Defects in <i>PEX7</i> can result in at least two phenotypes distinct from RCDP1:</p><ul><li class="half_rhythm"><div>Isolated <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts</div></li><li class="half_rhythm"><div>A disorder similar to adult <a href="/books/n/gene/refsum/">Refsum disease</a></div></li></ul><p>In both disorders, plasmalogen biosynthesis is nearly normal, although phytanic acid oxidation in skin fibroblast assays is severely reduced [<a class="bk_pop" href="#rcdp.REF.braverman.2002.284">Braverman et al 2002</a>, <a class="bk_pop" href="#rcdp.REF.van_den_brink.2003.471">van den Brink et al 2003</a>].</p></div><div id="rcdp.Differential_Diagnosis"><h2 id="_rcdp_Differential_Diagnosis_">Differential Diagnosis</h2><p>The classic RCDP1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> can be mimicked by <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> deficiencies of either of two peroxisomal enzymes involved in plasmalogen biosynthesis, as well as by severe Conradi-H&#x000fc;nermann syndrome. In addition, several different disorders, described below, have similar punctate cartilaginous changes and various combinations of limb asymmetry, short stature, intellectual disability, cataracts, and skin changes. The radiologic finding of chondrodysplasia punctata (CDP) has been observed in various metabolic disorders, skeletal dysplasias, <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> abnormalities, and teratogen exposures. Exhaustive classifications of CDP have been published [<a class="bk_pop" href="#rcdp.REF.irving.2008.229">Irving et al 2008</a>].</p><ul><li class="half_rhythm"><div><b>Rhizomelic chondrodysplasia punctata, type 2 (RCDP2) and type 3 (RCDP3).</b> RCDP2 is caused by deficiency of the peroxisomal enzyme dihydroxyacetone phosphate acyltransferase, encoded by <i>GNPAT</i> (OMIM <a href="http://omim.org/entry/602744" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">602744</a>). RCDP3 is caused by deficiency of the peroxisomal enzyme alkyl-dihydroxyacetone phosphate synthase, encoded by <i>AGPS</i> (OMIM <a href="http://omim.org/entry/600121" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">600121</a>). The clinical phenotypes resemble that seen in RCDP1, emphasizing the role of plasmalogen deficiency in determining the RCDP <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. RCDP2 and RCDP3 are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner and are rarer than RCDP1. The specific enzyme defect is confirmed by measurement of the enzyme activity in cultured skin fibroblasts and/or identification of two pathogenic variants by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>AGPS</i> or <i>GNPAT</i>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/cdp1-xlr/"><b>X-linked recessive chondrodysplasia punctata</b></a><b>, or brachytelephalangic type (CDPX1)</b> is caused by defects in arylsulfatase E (ARSE), a vitamin K-dependent enzyme encoded by <i>ARSL</i>. Affected males have hypoplasia of the distal phalanges without limb shortening or cataracts. The diagnosis is confirmed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions involving <i>ARSL</i> result in more complex phenotypes, including ichthyosis and corneal opacities resulting from steroid sulfatase deficiency.</div></li><li class="half_rhythm"><div><b>Warfarin embryopathy and other fetal vitamin K deficiencies</b> (including vitamin K epoxide reductase deficiency (OMIM <a href="http://omim.org/entry/277450" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">277450</a>]) are phenotypically similar to CDPX1.</div></li><li class="half_rhythm"><div><b>Maternal systemic lupus erythematosis (SLE)</b> (OMIM <a href="http://omim.org/entry/152700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">152700</a>) and other maternal autoimmune diseases can cause CDP in the offspring that is phenotypically similar to CDPX1.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/x-dcdp/"><b>X-linked dominant chondrodysplasia punctata</b></a><b>, or Conradi-H&#x000fc;nermann syndrome (CDPX2)</b> is usually lethal in males. It is caused by defects in sterol- &#x00394;8-isomerase which catalyzes an intermediate step in the conversion of lanosterol to cholesterol. <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> in females results in phenotypic variability and asymmetric findings. Cataracts are sectorial and limb shortening is rhizomesomelic and usually asymmetric. Severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants have bilateral findings resembling those of RCDP1. The diagnosis is confirmed by measuring the plasma concentration of sterols, which show accumulation of the precursors 8(9)-cholestenol and 8-dehydrocholesterol and/or identification of two pathogenic variants by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>EBP</i>.</div></li><li class="half_rhythm"><div><b>Chondrodysplasia punctata, tibia-metacarpal type</b> (OMIM <a href="http://omim.org/entry/118651" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">118651</a>) and <b>humero-metacarpal type</b> [<a class="bk_pop" href="#rcdp.REF.fryburg.1996.493">Fryburg &#x00026; Kelly 1996</a>] are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) in which mutation is causative are unknown. Affected individuals have short metacarpals with shortening of various long bones. No cataracts or skin changes are present.</div></li></ul></div><div id="rcdp.Management"><h2 id="_rcdp_Management_">Management</h2><div id="rcdp.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with rhizomelic chondrodysplasia punctata type I (RCDP1), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Full skeletal survey (with flexion and extension views of the neck)</div></li><li class="half_rhythm"><div>Ophthalmologic examination</div></li><li class="half_rhythm"><div>Growth parameters</div></li><li class="half_rhythm"><div>Developmental assessment</div></li><li class="half_rhythm"><div>MR imaging of brain (with MR spectroscopy)</div></li><li class="half_rhythm"><div>Cardiac ultrasound examination</div></li><li class="half_rhythm"><div>Renal ultrasound examination</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="rcdp.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Management is supportive and limited because of the multiple handicaps present at birth and the poor outcome.</p><p>Cataract extraction may preserve some vision.</p><p>Physical therapy is recommended to assist in the improvement of contractures; orthopedic procedures have improved function in some individuals.</p></div><div id="rcdp.Prevention_of_Primary_Manifestation"><h3>Prevention of Primary Manifestations</h3><p>Dietary restriction of phytanic acid to avoid the consequences of phytanic acid accumulation over time may benefit individuals with milder forms of RCDP.</p></div><div id="rcdp.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Poor feeding and recurrent aspiration necessitate the placement of a gastrostomy tube. Note: Improved nutrition does not enhance linear growth.</p><p>Individuals with RCDP1 require good pulmonary toilet and careful attention to respiratory function. Influenza vaccine and RSV monoclonal antibody should be provided.</p><p>Low plasmalogen levels can be associated with low levels of docosohexanoic acid (DHA). DHA can be measured in plasma; oral supplementation should be provided if levels are low.</p></div><div id="rcdp.Surveillance"><h3>Surveillance</h3><p>Based on a retrospective review of the natural history of 35 individuals with RCDP, <a class="bk_pop" href="#rcdp.REF.white.2003.332">White et al [2003]</a> provide health supervision guidelines for primary caretakers of children with RCDP, including the following:</p><ul><li class="half_rhythm"><div>Growth curves that allow weight comparisons to help determine the need for gastrostomy</div></li><li class="half_rhythm"><div>The ages at which developmental milestones are achieved to provide realistic expectations</div></li><li class="half_rhythm"><div>Recommendations for medical assessments including seizure control, vision, hearing, orthopedic care, and prevention of respiratory infections and contractures</div></li></ul></div><div id="rcdp.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#rcdp.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="rcdp.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="rcdp.Other"><h3>Other</h3><p>Data suggest that oral plasmalogen supplementation using alkylglycerol sources can increase tissue plasmalogen concentrations in rodents and red blood cell (RBC) plasmalogen concentrations in individuals with <a href="/books/n/gene/pbd/">Zellweger syndrome spectrum disorders</a>. Anecdotal reports of alkylglycerol supplementation in a few individuals with classic RCDP1 have not indicated dramatic clinical benefit; however, alkylglycerol supplementation has not yet been studied in a systematic fashion. Studies in <i>Pex7</i>-deficient mouse models have shown that plasmalogen precursors can partially recover plasmalogen levels in body tissues, but not in brain [<a class="bk_pop" href="#rcdp.REF.brites.2004.219">Brites et al 2004</a>, <a class="bk_pop" href="#rcdp.REF.wood.2011.182">Wood et al 2011</a>]</p><p>Nonsense suppressor drugs were unable to recover protein production in individuals with the common <a class="figpopup" href="/books/NBK1270/table/rcdp.T.selected_pex7_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figrcdpTselectedpex7pathogenicvariants" rid-ob="figobrcdpTselectedpex7pathogenicvariants">p.Leu292Ter</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#rcdp.REF.dranchak.2011.1250">Dranchak et al 2011</a>].</p></div></div><div id="rcdp.Genetic_Counseling"><h2 id="_rcdp_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="rcdp.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>RCDP1 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="rcdp.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> are obligate heterozygotes (carriers) and therefore carry one pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</div></li><li class="half_rhythm"><div>Heterozygotes are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a 25% chance of inheriting both pathogenic alleles and being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of inheriting one pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> and being an unaffected <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of inheriting both normal alleles.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the risk of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Affected individuals do not reproduce.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="rcdp.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carriers cannot be identified by biochemical methods.</p><p>Carrier testing of at-risk relatives using molecular genetic techniques is possible if the pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</p></div><div id="rcdp.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="rcdp.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>PEX7</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>Biochemical testing.</b> Prenatal diagnosis for pregnancies at 25% risk for RCDP1 is also possible by assay of plasmalogen biosynthesis in cultured chorionic villi obtained by CVS (usually performed at ~10-12 weeks' gestation) or in cultured amniocytes obtained by amniocentesis (usually performed at ~15-18 weeks' gestation).</p><p>The determination of enzyme activity of alkyl-dihydroxyacetone phosphate synthase (AGPS) and the subcellular localization of peroxisomal thiolase have also been performed successfully on uncultured chorionic villi.</p><p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p><p><b>Ultrasound examination.</b> Rhizomelia and punctate calcifications have been noted on ultrasound examination as early as 18 to 19 weeks [<a class="bk_pop" href="#rcdp.REF.krakow.2003.467">Krakow et al 2003</a>, <a class="bk_pop" href="#rcdp.REF.zwijnenburg.2010.162">Zwijnenburg et al 2010</a>]. Others have reported these findings along with bilateral cataracts at 32 weeks, and epiphyseal stippling shown four weeks later [<a class="bk_pop" href="#rcdp.REF.ba_bu_.2005.171">Ba&#x0015f;bu&#x0011f; et al 2005</a>]. Homozygosity of the <a class="figpopup" href="/books/NBK1270/table/rcdp.T.selected_pex7_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figrcdpTselectedpex7pathogenicvariants" rid-ob="figobrcdpTselectedpex7pathogenicvariants">p.Leu292Ter</a> variant in <i>PEX7</i> was verified in the case reported by <a class="bk_pop" href="#rcdp.REF.zwijnenburg.2010.162">Zwijnenburg et al [2010]</a>.</p></div></div><div id="rcdp.Resources"><h2 id="_rcdp_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>RhizoKids</b></div><div><a href="http://rhizokids.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.rhizokids.com</a></div></li><li class="half_rhythm"><div><b>Little People of America, Inc. (LPA)</b></div><div>250 El Camino Real</div><div>Suite 201</div><div>Tustin CA 92780</div><div><b>Phone:</b> 888-572-2001 (toll-free); 714-368-3689</div><div><b>Fax:</b> 714-368-3367</div><div><b>Email:</b> info@lpaonline.org</div><div><a href="http://www.lpaonline.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.lpaonline.org</a></div></li><li class="half_rhythm"><div><b>International Skeletal Dysplasia Registry</b></div><div>UCLA</div><div>615 Charles E. Young Drive</div><div>South Room 410</div><div>Los Angeles CA 90095-7358</div><div><b>Phone:</b> 310-825-8998</div><div><b>Fax:</b> 310-206-5266</div><div><b>Email:</b> Salon@mednet.ucla.edu</div><div><a href="https://www.uclahealth.org/ortho/isdr" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International Skeletal Dysplasia Registry</a></div></li></ul></div><div id="rcdp.Molecular_Genetics"><h2 id="_rcdp_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="rcdp.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Rhizomelic Chondrodysplasia Punctata Type 1: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1270/table/rcdp.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rcdp.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_rcdp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_rcdp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_rcdp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_rcdp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_rcdp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_rcdp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_rcdp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5191" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEX7</i></a></td><td headers="hd_b_rcdp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5191" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6q23<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_rcdp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O00628" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peroxisomal targeting signal 2 receptor</a></td><td headers="hd_b_rcdp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.dbpex.org/index.php?select_db=PEX7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dbPEX, PEX7 Gene Database</a><br /><a href="http://databases.lovd.nl/shared/genes/PEX7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX7 database</a></td><td headers="hd_b_rcdp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEX7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX7</a></td><td headers="hd_b_rcdp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEX7[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX7</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="rcdp.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="rcdp.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Rhizomelic Chondrodysplasia Punctata Type 1 (<a href="/omim/215100,601757" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1270/table/rcdp.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rcdp.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/215100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">215100</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601757" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601757</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS FACTOR 7; PEX7</td></tr></tbody></table></div></div><div id="rcdp.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><b>Role of the peroxisome targeting signal 2 receptor, PEX7, in peroxisome assembly.</b> Peroxisomal matrix enzymes are synthesized on free polyribosomes and directed to the peroxisome by cytosolic receptors. The peroxisome targeting signal 1 receptor (encoded by <i>PEX5</i>) binds a C-terminal peroxisome targeting signal, PTS1, present on most matrix proteins. PEX7 binds an N-terminal PTS2, present on three. The two receptors themselves interact and carry their protein cargo to the peroxisome membrane; the matrix proteins are then translocated inside, the import complex is disassembled, and the receptors are recycled for another round of import. This import process, along with the formation of new peroxisomes and division of existing ones, is termed peroxisome biogenesis. Fourteen human proteins are required for peroxisome biogenesis; collectively they are called peroxins and they are encoded by <i>PEX</i> genes.</p><p><b>Metabolic pathways dependent on PEX7.</b> The three PTS2 proteins transported to the peroxisome by PEX7 are alkyl-dihydroxyacetone phosphate synthase (AGPS), phytanoyl-CoA hydroxylase (PhyH), and peroxisomal 3-ketoacyl-CoA thiolase (ACAA1).</p><ul><li class="half_rhythm"><div><b>AGPS</b> catalyzes the initial steps of plasmalogen biosynthesis in a complex with the PTS1 protein, dihydroxyacetone phosphate acyltransferase (GNPAT). Plasmalogens are a class of membrane phospholipids, in which the fatty acid at the C1 position of the glycerophospholipid is replaced by a fatty alcohol. Plasmalogens are present in significant proportions in plasma membranes and myelin, and their specific functions are now being investigated [<a class="bk_pop" href="#rcdp.REF.braverman.2012.1442">Braverman &#x00026; Moser 2012</a>]. These compounds may protect against oxidative damage, be required for membrane fusion and fission processes, and function as lipid messengers. Since <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> defects in GNPAT or AGPS also result in RCDP (RCDP types 2 and 3), plasmalogen deficiency must play a major role in the pathogenesis of this disorder.</div></li><li class="half_rhythm"><div><b>PhYH</b> catalyzes the initial step in the catabolism of phytanic acid, a 16-carbon methyl-branched fatty acid of dietary origin. Isolated defects in PhYH cause adult <a href="/books/n/gene/refsum/">Refsum disease</a>.</div></li><li class="half_rhythm"><div><b>Peroxisomal thiolase (ACAA1)</b> catalyzes the last step in beta oxidation of very long straight-chain fatty acids. Beta oxidation is normal in RCDP1, presumably because the thiolase activity of sterol carrier protein-X, a PTS1 protein, compensates for this deficiency.</div></li><li class="half_rhythm"><div>Other proteins with PTS2 targeting signals have been recently identified by bioinformatics and proteomics experiments [<a class="bk_pop" href="#rcdp.REF.wiese.2007.2045">Wiese et al 2007</a>, <a class="bk_pop" href="#rcdp.REF.kunze.2011.45048">Kunze et al 2011</a>]. Their role in human disease caused by mutation of <i>PEX7</i> is not known.</div></li></ul><p><b>Gene structure.</b>
<i>PEX7</i> contains ten exons that span 91 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1270/#rcdp.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> No benign variants have been identified yet in the coding sequence.</p><p><b>Pathogenic variants.</b> Approximately 39 unique <i>PEX7</i> pathogenic variants have been identified thus far (see <a href="http://www.dbpex.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dbpex.org</a>). The majority are <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, or <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants, small insertions, or deletions. The pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> p.Leu292Ter accounts for 51% of alleles; less common alleles are c.903+1G&#x0003e;C, p.Gly217Arg, p.Ala218Val, and p.Tyr40Ter.</p><p>Alleles associated with milder RCDP phenotypes, variant phenotypes, or adult Refsum disease are either <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> alleles located on the surfaces of the PEX7 protein and thus unlikely to disrupt its structural integrity (p.Ser25Phe, p.His285Arg, p.Thr14Pro), or "leaky" alleles, potentially able to generate residual amounts of normal PEX7 protein (c.-45C&#x0003e;T,c.442-10A&#x0003e;G) and re-initiate translation <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> (p.His18ArgfsTer35) or at a downstream methionine residue (p.Gly7ValfsTer51) [<a class="bk_pop" href="#rcdp.REF.braverman.2002.284">Braverman et al 2002</a>, <a class="bk_pop" href="#rcdp.REF.motley.2002.612">Motley et al 2002</a>, <a class="bk_pop" href="#rcdp.REF.van_den_brink.2003.471">van den Brink et al 2003</a>].</p><div id="rcdp.T.selected_pex7_pathogenic_variants" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected <i>PEX7</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1270/table/rcdp.T.selected_pex7_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rcdp.T.selected_pex7_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.-45C&#x0003e;T</td><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_3" rowspan="11" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/197927204" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000288<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/4505731" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000279<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.340-10A&#x0003e;G<br />(IVS3-10A&#x0003e;G)</td><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.45_52dupGGGACGCC<br />(52insGGGACGCC)</td><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His18ArgfsTer35</td></tr><tr><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.12_18dupGTGCGGT</td><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly7ValfsTer51</td></tr><tr><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.74C&#x0003e;T</td><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser25Phe</td></tr><tr><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.854A&#x0003e;G</td><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His285Arg</td></tr><tr><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.40A&#x0003e;C</td><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr14Pro</td></tr><tr><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.903+1G&#x0003e;C<br />(IVS9+1G&#x0003e;C)</td><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.649G&#x0003e;A</td><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly217Arg</td></tr><tr><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.653C&#x0003e;T</td><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala218Val</td></tr><tr><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.875T&#x0003e;A</td><td headers="hd_h_rcdp.T.selected_pex7_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu292Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="rcdp.TF.4.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> PEX7, the peroxisome-targeting signal 2 receptor, is a 323-amino acid protein with serial WD40 repeats (short structural motif of approximately 40 amino acids, often terminating in a tryptophan-aspartic acid (W-D) dipeptide). These repeat domains fold into blades of a propeller-like structure, which resembles a torus on its side and provides several surfaces for protein interactions [<a class="bk_pop" href="#rcdp.REF.braverman.2002.284">Braverman et al 2002</a>]. PEX7 is a receptor for a subclass of peroxisomal matrix enzymes and binds the PTS2 signal at the N-terminus of these proteins. PEX7 carries its cargo to the peroxisome membrane by virtue of its interaction with PEX5.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Defects in <i>PEX7</i> result in deficient activity of PTS2 enzymes, but other peroxisomal functions remain intact. Fibroblast assays show that PTS2 proteins remain cytosolic in individuals with RCDP1 and are degraded, but PTS1 proteins are imported into peroxisomes normally. Peroxisome morphology is normal in fibroblasts but abnormal in liver, according to several case reports.</p></div></div><div id="rcdp.References"><h2 id="_rcdp_References_">References</h2><div id="rcdp.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.alkan.2003.77">Alkan A, Kutlu R, Yakinci C, Sigirci A, Aslan M, Sarac K. Delayed myelination in a rhizomelic chondrodysplasia punctata case: MR spectroscopy findings. <span><span class="ref-journal">Magn Reson Imaging. </span>2003;<span class="ref-vol">21</span>:77–80.</span> [<a href="/pubmed/12620550" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12620550</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.bamsmengerink.2006.798">Bams-Mengerink AM, Majoie CBLM, Duran M, Wanders RJA, Van Hove J, Scheurer CD, Barth PG, Poll-The BT. MRI of the brain and certical spinal cord in rhizomelic chondrodysplasia punctata. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">66</span>:798–803.</span> [<a href="/pubmed/16567694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16567694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.ba_bu_.2005.171">Ba&#x0015f;bu&#x0011f; M, Serin IS, Oz&#x000e7;elik B, Gune&#x0015f; T, Ak&#x000e7;aku&#x0015f; M, Tayyar M. Prenatal ultrasonographic diagnosis of rhizomelic chondrodysplasia punctata by detection of rhizomelic shortening and bilateral cataracts. <span><span class="ref-journal">Fetal Diagn Ther. </span>2005;<span class="ref-vol">20</span>:171–4.</span> [<a href="/pubmed/15824492" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15824492</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.braverman.2002.284">Braverman N, Chen L, Lin P, Obie C, Steel G, Douglas P, Chakraborty PK, Clarke JT, Boneh A, Moser A, Moser H, Valle D. Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype. <span><span class="ref-journal">Hum Mutat. </span>2002;<span class="ref-vol">20</span>:284–97.</span> [<a href="/pubmed/12325024" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12325024</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.braverman.2000.181">Braverman N, Steel G, Lin P, Moser A, Moser H, Valle D. PEX7 gene structure, alternative transcripts, and evidence for a founder haplotype for the frequent RCDP allele, L292ter. <span><span class="ref-journal">Genomics. </span>2000;<span class="ref-vol">63</span>:181–92.</span> [<a href="/pubmed/10673331" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10673331</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.braverman.2012.1442">Braverman NE, Moser AB. Functions of plasmalogen lipids in health and disease. <span><span class="ref-journal">Biochim Biophys Acta. </span>2012;<span class="ref-vol">1822</span>:1442–52.</span> [<a href="/pubmed/22627108" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22627108</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.brites.2004.219">Brites P, Waterham HR, Wanders RJ. Functions and biosynthesis of plasmalogens in health and disease. <span><span class="ref-journal">Biochim Biophys Acta. </span>2004;<span class="ref-vol">1636</span>:219–31.</span> [<a href="/pubmed/15164770" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15164770</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.dranchak.2011.1250">Dranchak PK, Di Pietro E, Snowden A, Oesch N, Braverman NE, Steinberg SJ, Hacia JG. Nonsense suppressor therapies rescue peroxisome lipid metabolism and assembly in cells from patients with specific PEX gene mutations. <span><span class="ref-journal">J Cell Biochem. </span>2011;<span class="ref-vol">112</span>:1250–8.</span> [<a href="/pmc/articles/PMC3136445/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3136445</span></a>] [<a href="/pubmed/21465523" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21465523</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.fryburg.1996.493">Fryburg JS, Kelly TE. Chondrodysplasia punctata, humero-metacarpal type: a second case. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">64</span>:493–6.</span> [<a href="/pubmed/8862628" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8862628</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.irving.2008.229">Irving MD, Chitty LS, Mansour S, Hall CM. Chondrodysplasia punctata: a clinical diagnostic and radiological review. <span><span class="ref-journal">Clin Dysmorphol. </span>2008;<span class="ref-vol">17</span>:229–41.</span> [<a href="/pubmed/18978650" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18978650</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.khanna.2001.63">Khanna AJ, Braverman NE, Valle D, Sponseller PD. Cervical stenosis secondary to rhizomelic chondrodysplasia punctata. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">99</span>:63–6.</span> [<a href="/pubmed/11170096" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11170096</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.krakow.2003.467">Krakow D, Williams J 3rd, Poehl M, Rimoin DL, Platt LD. Use of three-dimensional ultrasound imaging in the diagnosis of prenatal-onset skeletal dysplasias. <span><span class="ref-journal">Ultrasound Obstet Gynecol. </span>2003;<span class="ref-vol">21</span>:467–72.</span> [<a href="/pubmed/12768559" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12768559</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.kunze.2011.45048">Kunze M, Neuberger G, Maurer-Stroh S, Ma J, Eck T, Braverman N, Schmid JA, Eisenhaber F, Berger J. Structural requirements for interaction of peroxisomal targeting signal 2 and its receptor PEX7. <span><span class="ref-journal">J Biol Chem. </span>2011;<span class="ref-vol">286</span>:45048–62.</span> [<a href="/pmc/articles/PMC3247985/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3247985</span></a>] [<a href="/pubmed/22057399" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22057399</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.motley.2002.612">Motley AM, Brites P, Gerez L, Hogenhout E, Haasjes J, Benne R, Tabak HF, Wanders RJ, Waterham HR. Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">70</span>:612–24.</span> [<a href="/pmc/articles/PMC384941/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC384941</span></a>] [<a href="/pubmed/11781871" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11781871</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.oswald.2011.3160">Oswald G, Lawson C, Raymond G, Golden WC, Braverman N. Rhizomelic chondrodysplasia punctata type 1 and fulminant neonatal respiratory failure, a case report and discussion of pathophysiology. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:3160–3.</span> [<a href="/pubmed/22052861" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22052861</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.powers.1999.129">Powers JM, Kenjarski TP, Moser AB, Moser HW. Cerebellar atrophy in chronic rhizomelic chondrodysplasia punctata: a potential role for phytanic acid and calcium in the death of its Purkinje cells. <span><span class="ref-journal">Acta Neuropathol (Berl). </span>1999;<span class="ref-vol">98</span>:129–34.</span> [<a href="/pubmed/10442551" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10442551</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.van_den_brink.2003.471">van den Brink DM, Brites P, Haasjes J, Wierzbicki AS, Mitchell J, Lambert-Hamill M, de Belleroche J, Jansen GA, Waterham HR, Wanders RJ. Identification of PEX7 as the second gene involved in Refsum disease. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:471–7.</span> [<a href="/pmc/articles/PMC379239/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC379239</span></a>] [<a href="/pubmed/12522768" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12522768</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.white.2003.332">White AL, Modaff P, Holland-Morris F, Pauli RM. Natural history of rhizomelic chondrodysplasia punctata. <span><span class="ref-journal">Am J Med Genet. </span>2003;<span class="ref-vol">118A</span>:332–42.</span> [<a href="/pubmed/12687664" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12687664</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.wiese.2007.2045">Wiese S, Gronemeyer T, Ofman R, Kunze M, Grou CP, Almeida JA, Eisenacher M, Stephan C, Hayen H, Schollenberger L, Korosec T, Waterham HR, Schliebs W, Erdmann R, Berger J, Meyer HE, Just W, Azevedo JE, Wanders RJ, Warscheid B. Proteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profiling. <span><span class="ref-journal">Mol Cell Proteomics. </span>2007;<span class="ref-vol">6</span>:2045–57.</span> [<a href="/pubmed/17768142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17768142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.wood.2011.182">Wood PL, Khan MA, Smith T, Ehrmantraut G, Jin W, Cui W, Braverman NE, Goodenowe DB. In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor. <span><span class="ref-journal">Lipids Health Dis. </span>2011;<span class="ref-vol">10</span>:182.</span> [<a href="/pmc/articles/PMC3238230/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3238230</span></a>] [<a href="/pubmed/22008564" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22008564</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rcdp.REF.zwijnenburg.2010.162">Zwijnenburg PJ, Deurloo KL, Waterham HR, Meijers-Heijboer EJ, van Vugt JM, Tan-Sindhunata MB. Second trimester prenatal diagnosis of rhizomelic chondrodysplasia punctata type 1 on ultrasound findings. <span><span class="ref-journal">Prenat Diagn. </span>2010;<span class="ref-vol">30</span>:162–4.</span> [<a href="/pubmed/20014169" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20014169</span></a>]</div></li></ul></div></div><div id="rcdp.Chapter_Notes"><h2 id="_rcdp_Chapter_Notes_">Chapter Notes</h2><div id="rcdp.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>13 September 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>2 March 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 July 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 February 2005 (cd) Revision: test availability</div></li><li class="half_rhythm"><div>26 February 2004 (cd) Revision: test availability</div></li><li class="half_rhythm"><div>13 February 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>16 November 2001 (me) Review posted live</div></li><li class="half_rhythm"><div>10 June 2001 (nb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1270</span><span class="label">PMID: <a href="/pubmed/20301447" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301447</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/rtps/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/riboflavin-tn/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1270&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1270/?report=reader">PubReader</a></li><li><a href="/books/NBK1270/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1270" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1270" style="display:none" title="Cite this Page"><div class="bk_tt">Braverman NE, Moser AB, Steinberg SJ. Rhizomelic Chondrodysplasia Punctata Type 1. 2001 Nov 16 [Updated 2012 Sep 13]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1270/pdf/Bookshelf_NBK1270.pdf">PDF version of this page</a> (445K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#rcdp.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#rcdp.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#rcdp.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#rcdp.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#rcdp.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#rcdp.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#rcdp.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#rcdp.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#rcdp.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#rcdp.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#rcdp.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5191[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PEX7</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1270+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1469756" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1469756" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1469756" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1469756" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301621" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Zellweger Spectrum Disorder</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Zellweger Spectrum Disorder<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Steinberg SJ, Raymond GV, Braverman NE, Moser AB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20060764" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton.</a><span class="source">[Mol Genet Metab. 2010]</span><div class="brieflinkpop offscreen_noflow">A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Braverman N, Zhang R, Chen L, Nimmo G, Scheper S, Tran T, Chaudhury R, Moser A, Steinberg S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Genet Metab. 2010 Apr; 99(4):408-16. Epub 2009 Dec 11.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21634086" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Chondrodysplasia Punctata 2, X-Linked</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Chondrodysplasia Punctata 2, X-Linked<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dempsey MA, Tan C, Herman GE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28742517" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Type 1 rhizomelic chondrodysplasia punctata with a homozygous PEX7 mutation.</a><span class="source">[J Pediatr Endocrinol Metab. 2017]</span><div class="brieflinkpop offscreen_noflow">Type 1 rhizomelic chondrodysplasia punctata with a homozygous PEX7 mutation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Muratoğlu Şahin N, Bilici ME, Kurnaz E, Pala Akdoğan M, Ceylaner S, Aycan Z. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Pediatr Endocrinol Metab. 2017 Aug 28; 30(8):889-892. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28898320" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">[Peroxisomal disorder, rhizomelyc chondrodysplasia punctata type 1: case report].</a><span class="source">[Rev Chil Pediatr. 2017]</span><div class="brieflinkpop offscreen_noflow">[Peroxisomal disorder, rhizomelyc chondrodysplasia punctata type 1: case report].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">González-Ortiz CL, Jaimes Leguizamón SB, Contreras-García GA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Rev Chil Pediatr. 2017; 88(4):511-516. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301447" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301447" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04156adde089116900327f">Rhizomelic Chondrodysplasia Punctata Type 1 - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Rhizomelic Chondrodysplasia Punctata Type 1 - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:05:30-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D5E73E04137810000000000E90056&amp;ncbi_session=CE8D5E73E0415691_0233SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1270%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1270&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1270/&amp;ncbi_pagename=Rhizomelic Chondrodysplasia Punctata Type 1 - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D5E73E0415691_0233SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>